Dick J E
Program in Cancer, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
Ann N Y Acad Sci. 1999 Apr 30;872:211-7; discussion 217-9. doi: 10.1111/j.1749-6632.1999.tb08466.x.
The availability of in vivo repopulation assays has greatly aided the study of human hematopoietic stem cells. Here, I shall review recent data that has identified a novel class of human repopulating cells that do not express classical stem cell markers including CD34 but still retain the ability to repopulate nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice.
体内再增殖试验的可用性极大地促进了对人类造血干细胞的研究。在此,我将回顾最近的数据,这些数据鉴定出了一类新型的人类再增殖细胞,它们不表达包括CD34在内的经典干细胞标志物,但仍保留再增殖非肥胖糖尿病/重症联合免疫缺陷(NOD/SCID)小鼠的能力。